Experts from the CU Alzheimer's and Cognition Center, formerly known as the Rocky Mountain Alzheimer's Disease Center, are commonly interviewed and featured in local and national news articles. This page lists an up-to-date collection of news pieces that feature one of our many experts in the field of Alzheimer's and Cognition research. You can also find a list of all podcasts featuring CU Alzheimer's and Cognition Center experts here.
[Grey Matter] refers to regions throughout the brain where nerve cells – known as neurons – are concentrated, according to Dr. Christopher M. Filley, a professor of neurology and psychiatry and the director of the behavioral neurology section at the University of Colorado Medical School.
“All three of the teams exemplified [the importance of team efforts behind the research],” Chiang says. “I really love the spirit of all of you. The reason that we’re doing this is to cure blindness, eliminate vision loss, and improve quality of life.” - NEI director Dr. Michael Chiang
That then allowed us to apply for a grant to study young adults with Down syndrome before they get Alzheimer's disease - Dr. Huntington Potter, quote from NPR story
We took a unique approach by targeting APOE4 because the usual drug targets, amyloid-beta and tau, have not produced a convincingly effective drug for people with AD despite decades of work - Dr. Noah Johnson, quote from CU Anschutz Today article
We as doctors can do all we want and all we can to help manage medication and appointments, but the difference that affected everyone in this pandemic is loss of access to community services - Dr. Sanders, quote from CU Anschutz Today article
Understanding white matter is perhaps a key to understanding these disorders. But so far, researchers have generally not given white matter the attention it deserves. - Dr. Filley, quote from the Conversation article
My message to anybody with aphasia would be one of encouragement: to keep going - Dr. Pressman, quote from CU Anschutz Today
What our hope is if all the clinical trials are safe and successful, is that this drug would be able to improve the memory and cognition of people with Down Syndrome - Dr. Potter, quote from the Denver Channel 7 article
[research results] call into question the mandate of studying inflammation as a negative feature of Alzheimer's disease...we've now opened up a new way of thinking about Alzheimer's Disease therapy - Dr. Potter, quote from touchNEUROLOGY interview
I am worried that there may be a trigger for later Alzheimer's disease due to COVID - Dr. Huntington Potter, quote from 9news interview.
Zach Macchi, MD, behavioral neurologist for the CU Alzheimer's and Cognition Center, was on the Dementia Resilience podcast with Jill Lorentz to discuss care for people with early onset dementia and for caregivers, specifically from a neuro-palliative care perspective. They discuss how palliative care is not limited strictly to end-of-life care, and how it can be integrated into the standard care for Alzheimer's and dementia care.
Listen to the Podcast or Download Podcast Here
Many of the experts at the CU Alzheimer's and Cognition have been guests on Ms. Lorentz's podcast, and recordings of those podcasts can be found here.
Palliative care...is medicine that is really focused on quality of life, looking at all aspects of a patient's life, not just their disease - Dr. Zachary Macchi, quote from Dementia Resilience podcast
In this article, the Denver Post brought to light an unintended consequence of the social distancing measures put in place because of the COVID-19 pandemic - social isolation and its negative impact on people living with Alzheimer's disease. Two CU Alzheimer's and Cognition Center clinicians, Dr. Zachary Macchi and Dr. Samantha Holden provided insight as to why this may be happening.
A lot of caregivers have noticed sharp declines in their loved ones' cognitive abilities and ability to care for themselves - Dr. Zachary Macchi, quote from the Denver Post article
Samantha Holden, MD, behavioral neurologist for the CU Alzheimer's and Cognition Center and the director of the Memory Disorders Clinic, was interviewed by Jill Lorentz for her podcast series, Dementia Resilience. They discussed many things related to Alzheimer's disease and dementia, such as differentiating between Lewy Body Dementia and Parkinson's disease and the impact of COVID-19 on the Memory Disorder Clinic and people living with Alzheimer's disease and related dementias.
Listen to the Podcast or Download Podcast Here
Many of the experts at the CU Alzheimer's and Cognition have been guests on Ms. Lorentz's podcast, and recordings of those podcasts can be found here.
If we are going to come up with better treatments and cures, we need to know what we are dealing with. All dementia is not Alzheimer's, and all Alzheimer's is not dementia. - Dr. Samantha Holden, quote from Dementia Resilience Podcast
In a Q&A with CU Anschutz Today, Huntington Potter, PhD updated the University on the progress being made in finding a treatment for Alzheimer's disease at the CU Alzheimer's and Cognition Center, and the effect of COVID-19 on that progress.
Alzheimer's should be considered to be, if not a lifelong problem, at least a middle-age problem that should be addressed as soon as we have biomarkers that can identify people at risk. - Dr. Huntington Potter , quote from CU Anschutz Today Q&A